RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3041% above fair value
$76.04−2.04 (-2.61%)
Close on Nov 12, 2026Market cap $5.98BP/E –Yield –
RadNet ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
RadNet's ebitda for the twelve months ending Sep 30, 2026 was $252.01M, up 22.3% year over year. For fiscal 2025 it was $214.12M, down 11.7% from the year before. Over ten years it grew 7.9% a year on average. The highest annual figure on record is $242.46M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $214.12M | -11.7% |
| FY2024 | Dec 31, 2024 | $242.46M | +6.8% |
| FY2023 | Dec 31, 2023 | $227.09M | +40.0% |
| FY2022 | Dec 31, 2022 | $162.24M | -9.5% |
| FY2021 | Dec 31, 2021 | $179.25M | +46.3% |
| FY2020 | Dec 31, 2020 | $122.48M | -18.6% |
| FY2019 | Dec 31, 2019 | $150.49M | +45.0% |
| FY2018 | Dec 31, 2018 | $103.79M | -11.2% |
| FY2017 | Dec 31, 2017 | $116.85M | +11.2% |
| FY2016 | Dec 31, 2016 | $105.09M | +5.4% |
| FY2015 | Dec 31, 2015 | $99.73M | +545.9% |
| FY2014 | Dec 31, 2014 | $15.44M | -5.6% |
| FY2013 | Dec 31, 2013 | $16.36M | -5.1% |
| FY2012 | Dec 31, 2012 | $17.24M | +40.8% |
| FY2011 | Dec 31, 2011 | $12.25M | -4.3% |
| FY2010 | Dec 31, 2010 | $12.79M | -86.7% |
| FY2009 | Dec 31, 2009 | $95.90M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $77.27M | +15.0% |
| Q2 FY2026 | Jun 30, 2026 | $85.00M | +27.1% |
| Q1 FY2026 | Mar 31, 2026 | $21.06M | +85.1% |
| Q4 FY2025 | Dec 31, 2025 | $68.68M | +13.4% |
| Q3 FY2025 | Sep 30, 2025 | $67.19M | -2.5% |
| Q2 FY2025 | Jun 30, 2025 | $66.87M | -3.5% |
| Q1 FY2025 | Mar 31, 2025 | $11.38M | -74.0% |
| Q4 FY2024 | Dec 31, 2024 | $60.54M | +6.2% |
| Q3 FY2024 | Sep 30, 2024 | $68.89M | -8.7% |
| Q2 FY2024 | Jun 30, 2024 | $69.32M | +22.4% |
| Q1 FY2024 | Mar 31, 2024 | $43.71M | +15.1% |
| Q4 FY2023 | Dec 31, 2023 | $57.02M | +9.1% |
| Q3 FY2023 | Sep 30, 2023 | $75.46M | +108.7% |
| Q2 FY2023 | Jun 30, 2023 | $56.62M | +16.9% |
| Q1 FY2023 | Mar 31, 2023 | $37.99M | +49.6% |
| Q4 FY2022 | Dec 31, 2022 | $52.27M | +73.8% |
| Q3 FY2022 | Sep 30, 2022 | $36.15M | -36.8% |
| Q2 FY2022 | Jun 30, 2022 | $48.42M | -6.3% |
| Q1 FY2022 | Mar 31, 2022 | $25.40M | -37.0% |
| Q4 FY2021 | Dec 31, 2021 | $30.07M | -30.3% |
| Q3 FY2021 | Sep 30, 2021 | $57.18M | +28.1% |
| Q2 FY2021 | Jun 30, 2021 | $51.69M | +140.0% |
| Q1 FY2021 | Mar 31, 2021 | $40.31M | +206.3% |
| Q4 FY2020 | Dec 31, 2020 | $43.16M | -2.3% |
| Q3 FY2020 | Sep 30, 2020 | $44.62M | +19.5% |
| Q2 FY2020 | Jun 30, 2020 | $21.53M | -48.8% |
| Q1 FY2020 | Mar 31, 2020 | $13.16M | -51.1% |
| Q4 FY2019 | Dec 31, 2019 | $44.19M | +133.4% |
| Q3 FY2019 | Sep 30, 2019 | $37.34M | +10.1% |
| Q2 FY2019 | Jun 30, 2019 | $42.07M | +23.9% |
| Q1 FY2019 | Mar 31, 2019 | $26.89M | +58.5% |
| Q4 FY2018 | Dec 31, 2018 | $18.93M | -45.6% |
| Q3 FY2018 | Sep 30, 2018 | $33.93M | +21.6% |
| Q2 FY2018 | Jun 30, 2018 | $33.96M | +10.3% |
| Q1 FY2018 | Mar 31, 2018 | $16.97M | -27.5% |
| Q4 FY2017 | Dec 31, 2017 | $34.78M | +8.6% |
| Q3 FY2017 | Sep 30, 2017 | $27.89M | – |
| Q2 FY2017 | Jun 30, 2017 | $30.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $23.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $32.04M | – |
See a number that looks wrong?